170 related articles for article (PubMed ID: 10413462)
1. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
Greenwald J; Le V; Butler SL; Bushman FD; Choe S
Biochemistry; 1999 Jul; 38(28):8892-8. PubMed ID: 10413462
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase.
Yang ZN; Mueser TC; Bushman FD; Hyde CC
J Mol Biol; 2000 Feb; 296(2):535-48. PubMed ID: 10669607
[TBL] [Abstract][Full Text] [Related]
3. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases.
Maignan S; Guilloteau JP; Zhou-Liu Q; Clément-Mella C; Mikol V
J Mol Biol; 1998 Sep; 282(2):359-68. PubMed ID: 9735293
[TBL] [Abstract][Full Text] [Related]
5. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.
Heuer TS; Brown PO
Biochemistry; 1998 May; 37(19):6667-78. PubMed ID: 9578550
[TBL] [Abstract][Full Text] [Related]
6. Molecular dynamics studies of the full-length integrase-DNA complex.
De Luca L; Vistoli G; Pedretti A; Barreca ML; Chimirri A
Biochem Biophys Res Commun; 2005 Nov; 336(4):1010-6. PubMed ID: 16165087
[TBL] [Abstract][Full Text] [Related]
7. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
[TBL] [Abstract][Full Text] [Related]
8. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
Heuer TS; Brown PO
Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
[TBL] [Abstract][Full Text] [Related]
9. Conformational flexibility of PEP mutase.
Liu S; Lu Z; Han Y; Jia Y; Howard A; Dunaway-Mariano D; Herzberg O
Biochemistry; 2004 Apr; 43(15):4447-53. PubMed ID: 15078090
[TBL] [Abstract][Full Text] [Related]
10. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
[TBL] [Abstract][Full Text] [Related]
11. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the substrate specificity loop of the HAD superfamily cap domain.
Lahiri SD; Zhang G; Dai J; Dunaway-Mariano D; Allen KN
Biochemistry; 2004 Mar; 43(10):2812-20. PubMed ID: 15005616
[TBL] [Abstract][Full Text] [Related]
13. Active site binding modes of curcumin in HIV-1 protease and integrase.
Vajragupta O; Boonchoong P; Morris GM; Olson AJ
Bioorg Med Chem Lett; 2005 Jul; 15(14):3364-8. PubMed ID: 15950462
[TBL] [Abstract][Full Text] [Related]
14. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae.
Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH
J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
[TBL] [Abstract][Full Text] [Related]
16. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
17. Modeling HIV-1 integrase complexes based on their hydrodynamic properties.
Podtelezhnikov AA; Gao K; Bushman FD; McCammon JA
Biopolymers; 2003 Jan; 68(1):110-20. PubMed ID: 12579583
[TBL] [Abstract][Full Text] [Related]
18. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
Zhu HM; Chen WZ; Wang CX
Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the catalytic domain of gammadelta resolvase. Implications for the mechanism of catalysis.
Pan B; Maciejewski MW; Marintchev A; Mullen GP
J Mol Biol; 2001 Jul; 310(5):1089-107. PubMed ID: 11501998
[TBL] [Abstract][Full Text] [Related]
20. Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase.
Du L; Zhao YX; Yang LM; Zheng YT; Tang Y; Shen X; Jiang HL
Acta Pharmacol Sin; 2008 Oct; 29(10):1261-7. PubMed ID: 18817633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]